Vikram Solar Stock: Analyst Cuts Price Target Despite 'Buy' Rating

RENEWABLES
Whalesbook Logo
AuthorIshaan Verma|Published at:
Vikram Solar Stock: Analyst Cuts Price Target Despite 'Buy' Rating
Overview

Prabhudas Lilladher kept a 'BUY' rating for Vikram Solar but sharply lowered its price target to ₹226. Growth drivers include capacity expansion and BESS/global market dives. However, industry overcapacity, falling profit margins, and high valuations create near-term challenges despite a strong order book and integration efforts.

Analyst Maintains Buy Rating but Cuts Price Target

Prabhudas Lilladher has kept a 'BUY' rating on Vikram Solar but significantly reduced its price target to ₹226 from ₹326. This change follows an analyst meeting detailing the company's medium-term growth strategy. The company plans aggressive expansion across modules, cells, and wafer/ingot, aiming for full vertical integration by FY30. The brokerage expects strong annual growth (CAGR) for revenue, EBITDA, and PAT between FY26-28. However, the target price adjustment reflects a reduction in FY27/28 EBITDA estimates. This is due to the time needed to stabilize the cell manufacturing plant, expected by FY28. Vikram Solar's stock currently trades around ₹190.36, down roughly 45-48% year-to-date.

Expansion Plans Meet Industry Overcapacity Challenge

Vikram Solar is pushing for full vertical integration and diversifying into Battery Energy Storage Systems (BESS), targeting 15 GWh over five years. Global expansion, including a planned US entry in Q2 FY27, is also a key growth area, adding to a domestic order book of approximately 10.6 GW. This aggressive build-out is happening as concerns grow over industry overcapacity in India. Projections show solar module manufacturing capacity could exceed 165 GW by March 2027, far more than the expected annual solar capacity additions of 45-50 GW. This supply-demand imbalance, worsened by lower exports due to US tariffs, is expected to pressure prices and profits for manufacturers. While Vikram Solar's focus on integration aims to reduce margin loss, the scale of expected oversupply presents a significant challenge.

Valuation Concerns Compared to Peers

The company's current valuation metrics appear high compared to its peers. Vikram Solar trades at a P/E ratio of about 49.3x, which is considered expensive and trades at a premium to the sector's average P/E of 27.19. While some competitors like Waaree Energies have a larger scale and order books, others such as Saatvik Green or Waaree Renewable offer more attractive valuations with P/E ratios around 20-28x. The analyst's valuation at 5.0x EV of Mar’28E EBITDA offers another perspective, but the high P/E raises questions about whether its current stock price is sustainable amidst wider sector changes.

Risks: Margin Squeeze, Promoter Shares, and Rating Swings

Despite strong revenue growth recently, including a 93.7% year-over-year increase in Q2 FY26 revenue, the risk of shrinking profit margins is significant. Industry overcapacity, along with possible changes in raw material costs if full cell integration is delayed, directly threatens profitability. Furthermore, Vikram Solar faces a significant risk from its high promoter share pledging, with approximately 48.2% of shares pledged. This concentration can increase stock swings and worry investors. The company's investment rating has also seen considerable changes; one rating service downgraded the stock to 'Sell' in early March, citing promoter risks, only to upgrade it back to 'Hold' later in March, showing the shifting investor sentiment around the stock. Executing its ambitious BESS expansion also brings new operational and financial risks.

Outlook: Balancing Growth Plans with Current Challenges

Vikram Solar's strategy to achieve full vertical integration by FY30 and expand into BESS and global markets aims to drive long-term growth. The projected revenue CAGR of 65.1% between FY26-28 indicates potential for significant growth. However, the near-term outlook is overshadowed by widespread industry overcapacity, pressure on prices, and the company's own valuation. Investors will need to closely monitor margin performance, whether its cell manufacturing operations stabilize successfully, and the execution of its diversification strategies. This will be key to assessing its ability to navigate these challenges and support the ongoing 'Buy' recommendation, despite a significantly reduced target price.

Disclaimer:This content is for informational purposes only and does not constitute financial or investment advice. Readers should consult a SEBI-registered advisor before making decisions. Investments are subject to market risks, and past performance does not guarantee future results. The publisher and authors are not liable for any losses. Accuracy and completeness are not guaranteed, and views expressed may not reflect the publication’s editorial stance.